EAM
CRL icon

EFG Asset Management’s Charles River Laboratories CRL Stock Holding History

EFG Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,959
Closed -$1.65M – 182
2024
Q4 		$1.65M Sell
8,959
-2,845
-24% -$548K 0.23% 168
2024
Q3 		$2.32M Sell
11,804
-5,131
-30% -$1.07M 0.39% 111
2024
Q2 		$3.5M Buy
16,935
+1,571
+10% +$356K 0.61% 44
2024
Q1 		$4.16M Buy
15,364
+1,934
+14% +$462K 0.72% 37
2023
Q4 		$3.17M Sell
13,430
-598
-4% -$118K 0.6% 62
2023
Q3 		$2.75M Buy
14,028
+770
+6% +$158K 0.65% 55
2023
Q2 		$2.79M Buy
13,258
+2,167
+20% +$431K 0.6% 55
2023
Q1 		$2.24M Buy
+11,091
New +$2.51M 0.49% 67

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EFG Asset Management's CRL Position: Q1 2025 in Review

EFG Asset Management sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 8,959 shares — an estimated $1.65M sold.

EFG Asset Management first reported a position in CRL in Q1 2023 and held it in 8 quarters. The position peaked at $4.16M in Q1 2024. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • EFG Asset Management reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • EFG Asset Management sold 8,959 Charles River Laboratories shares in Q1 2025, an estimated $1.65M.
  • EFG Asset Management first reported a position in Charles River Laboratories in Q1 2023 and held it in 8 quarters.
  • EFG Asset Management's Charles River Laboratories position peaked at $4.16M in Q1 2024.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on EFG Asset Management's 13F filing for Q1 2025, filed 15 May 2025.